| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
86,370,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Beyond Air is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit® platform) capable of generating NO from ambient air. The LungFit® platform can generate NO for delivery to a patient's lungs directly or via a ventilator. LungFit® can deliver NO either continuously or for a fixed amount of time at various flow rates and has the ability to either titrate dose on demand or maintain a constant dose. LungFit® can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections via delivery through a breathing mask or similar apparatus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,006,000 |
4,248,518 |
5,874,957 |
| Total Buy Value |
$0 |
$252,344 |
$1,853,893 |
$4,877,533 |
| Total People Bought |
0 |
2 |
4 |
4 |
| Total Buy Transactions |
0 |
2 |
8 |
14 |
| Total Shares Sold |
0 |
0 |
0 |
28,423 |
| Total Sell Value |
$0 |
$0 |
$0 |
$59,030 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
3 |
| End Date |
2025-04-06 |
2025-01-03 |
2024-07-05 |
2023-07-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carey Robert |
Director |
– • – |
2025-03-14 |
4 |
B |
$0.25 |
$250,050 |
D/D |
1,000,000 |
4,076,864 |
2.39 |
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2025-02-19 |
4 |
B |
$0.38 |
$2,294 |
D/D |
6,000 |
94,150 |
2.66 |
- |
|
| Carey Robert |
Director |
– • – |
2024-09-26 |
4 |
B |
$0.50 |
$744,662 |
I/I |
1,476,626 |
1,476,626 |
2.1 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2024-09-26 |
4 |
B |
$0.50 |
$744,662 |
D/D |
1,476,626 |
3,249,411 |
2.81 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2024-08-15 |
4 |
B |
$0.37 |
$18,340 |
D/D |
50,000 |
1,772,785 |
2.81 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2024-08-14 |
4 |
B |
$0.39 |
$38,640 |
D/D |
100,000 |
1,722,785 |
2.81 |
- |
|
| Carey Robert |
Director |
– • – |
2024-08-14 |
4 |
B |
$0.40 |
$39,680 |
D/D |
100,000 |
3,076,864 |
2.39 |
- |
|
| Lucera Erick |
Director |
– • – |
2024-08-14 |
4 |
B |
$0.40 |
$15,565 |
D/D |
39,266 |
43,608 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2024-03-20 |
4 |
A |
$1.66 |
$1,000,001 |
D/D |
602,410 |
2,976,864 |
|
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2024-03-20 |
4 |
A |
$1.66 |
$130,001 |
D/D |
78,314 |
1,614,785 |
|
- |
|
| Larson Douglas Quinton |
Chief Financial Officer |
• – – |
2024-03-20 |
4 |
A |
$1.66 |
$20,000 |
D/D |
12,048 |
27,548 |
|
- |
|
| Avniel Amir |
Chief Business Officer |
• • – |
2023-12-28 |
4 |
S |
$2.05 |
$28,217 |
I/I |
(13,733) |
0 |
|
- |
|
| Avniel Amir |
Chief Business Officer |
• • – |
2023-12-28 |
4 |
S |
$2.06 |
$23,234 |
D/D |
(11,267) |
685,760 |
|
- |
|
| Myers Jeff Lynn |
Chief Medical Officer |
• – – |
2023-12-27 |
4 |
S |
$2.21 |
$7,579 |
D/D |
(3,423) |
46,577 |
|
- |
|
| Carey Robert |
Director |
– • – |
2023-12-18 |
4 |
B |
$1.64 |
$1,962,000 |
D/D |
1,200,000 |
2,374,454 |
2.39 |
- |
|
| Lisi Steven A. |
CEO and Chairman of the Board |
• • – |
2023-12-18 |
4 |
B |
$1.63 |
$126,797 |
D/D |
77,775 |
1,536,471 |
2.81 |
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2023-11-16 |
4 |
B |
$1.77 |
$17,700 |
D/D |
10,000 |
88,150 |
2.74 |
- |
|
| Carey Robert |
Director |
– • – |
2023-08-28 |
4 |
B |
$2.70 |
$673,750 |
D/D |
250,000 |
1,225,160 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2023-08-21 |
4 |
B |
$2.76 |
$207,453 |
D/D |
75,050 |
975,160 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2023-08-18 |
4 |
B |
$2.64 |
$35,940 |
D/D |
13,614 |
900,110 |
2.39 |
- |
|
| Gaul Michael A. |
Chief Operating Officer |
• – – |
2023-06-30 |
4 |
B |
$4.51 |
$22,550 |
D/D |
5,000 |
78,150 |
2.74 |
- |
|
| Carey Robert |
Director |
– • – |
2023-03-30 |
4 |
B |
$6.45 |
$64,500 |
D/D |
10,000 |
886,496 |
2.39 |
- |
|
| Carey Robert |
Director |
– • – |
2023-03-29 |
4 |
B |
$6.30 |
$63,000 |
D/D |
10,000 |
876,496 |
2.39 |
- |
|
| Lee Yoori |
Director |
– • – |
2023-03-28 |
4 |
B |
$6.34 |
$19,749 |
D/D |
3,115 |
12,654 |
2.39 |
- |
|
| Myers Jeff Lynn |
Chief Medical Officer |
• – – |
2023-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
173 Records found
|
|
Page 1 of 7 |
|
|
